Skip to content
Sign in
Venture capitalBacked 1 network startup

Max Ventures

Investor with no profile in our data; invested an undisclosed amount in Spanish femtech/preventive health startup IKI Health.

Ticket
—Not published
Assets under management
—
Founded
—
Stages
—
Network startups backed
1
Co-investors
0

How they invest

Unknown; one Spanish health deal.

Stage and ticket

Undisclosed.

Geography

Unknown.

What makes them say yes

  • Women's/preventive health (inferred)
  • Spanish ecosystem (ENISA co-backing)
  • Early stage

Red flags

  • No published thesis, ticket or stage policy in our data — any approach is a cold qualification call
  • Pitching outside the single sector signal visible in its known deal

Sectors

Not published

Stages

Not published

Geographies

Not published

How to approach

Ask IKI Health's founders for an introduction.

Portfolio

1 network startup · no other company

IKI Health alongside ENISA.

Gaps in the portfolio

  • Unknown thesis

Network startups

  • IKI HealthSWC 2026 Finalist

    Physician-founded Mallorca platform letting clinicians prescribe personalised lifestyle-medicine programmes, starting with menopause.

    Spain · HealthTech

    • investment (amount not disclosed)Source

Network startups that fit

3 analysed

Mexican menopause FemTech pairing saliva hormone kits with AI symptom tracking, already retailing in Hong Kong through Mannings pharmacies.

Mexican menopause femtech — women's health.

30%confidence

Evidence from the records

  • “IKI Health”
  • “FemTech – perimenopause / menopause”
  • “Kit sold in Hong Kong through the Mannings pharmacy chain.”
Intro path
Founder-to-founder intro via IKI Health (network portfolio company of Max Ventures).
First step
Qualify via IKI Health.

Melbourne start-up developing an at-home urine test with machine learning to screen for endometriosis.

Australian endometriosis diagnostics — women's health.

25%confidence

Evidence from the records

  • “IKI Health”
  • “Women's health diagnostics (endometriosis)”
  • “No public evidence of traction found (urine endometriosis test in development, no published clinical study identified).”
Intro path
Founder-to-founder intro via IKI Health (network portfolio company of Max Ventures).
First step
Qualify via IKI Health.

CE-marked, ISO 13485 dermatology AI that supports diagnosis and scores severity from photos, partnering with NHS and Spanish health services.

Spanish dermatology AI — Spanish health; already well funded.

20%confidence

Evidence from the records

  • “IKI Health”
  • “AI in dermatology (medical device)”
  • “CE-marked medical device (ISO 13485), with partners listed such as NHS, SERMAS, SESPA, Sanitas, Adeslas, Novartis and Almirall.”
Intro path
Founder-to-founder intro via IKI Health (network portfolio company of Max Ventures).
First step
Low priority.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

No co-investment documented yet.

Sources

  1. 1ecosistemastartup.com/?p=112561
  2. 2elreferente.es/?p=158906

Profile compiled from public sources. Unknown fields are left empty rather than estimated.